Retraction Note: The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway

Saved in:
Bibliographic Details
Published inJournal of experimental & clinical cancer research Vol. 44; no. 1
Main Authors He, Shanyang, Niu, Gang, Shang, Jianhong, Deng, Yalan, Wan, Zhiyong, Zhang, Cai, You, Zeshan, Shen, Hongwei
Format Journal Article
LanguageEnglish
Published BioMed Central Ltd 26.02.2025
Subjects
Antimitotic agents
Antineoplastic agents
Online AccessGet full text

Cover

Audience Academic
Author He, Shanyang
Wan, Zhiyong
You, Zeshan
Shang, Jianhong
Zhang, Cai
Deng, Yalan
Shen, Hongwei
Niu, Gang
Author_xml – sequence: 1
  fullname: He, Shanyang
– sequence: 2
  fullname: Niu, Gang
– sequence: 3
  fullname: Shang, Jianhong
– sequence: 4
  fullname: Deng, Yalan
– sequence: 5
  fullname: Wan, Zhiyong
– sequence: 6
  fullname: Zhang, Cai
– sequence: 7
  fullname: You, Zeshan
– sequence: 8
  fullname: Shen, Hongwei
BookMark eNptkc1KAzEQx3OoYK2-gKeA4G01afYj8VaLXyAK0ruM2ezu6DZZNrHVl_BpPHnUFzOLHirIMAzz5_cfhpkdMrLOGkL2OTviXObHnguW5gmbZgkTIk2TdETGTKhpolght8mO94-M5VxxNSbvdyb0oAM6S29cMCd00RjqrHa1sajphWtrpF3jfMyujwRaKmiLT5Famd68dL3xfrCjp-C90wjBlHSNoaEafddCiJYIoQ9gtaGxcyvoESzV0Gu0bgkUbEmHNVYDXdMQl7g5T77ePj9OqcfaQjvIHYRmDa-7ZKuC1pu93zohi_Ozxfwyub69uJrPrpNaSZXIMp8WsoCKAePagM559sAzFcWq5GlZSCaLrEyNyGQGSqRCa6lEBRJSkReFmJCDn7E1tOYebeWGUy3R6_uZnErFGI_8hBz9Q8UozRJ1fE2FUf9jONwwNAba0HjXPg8_8JvgN2g0k_g
ContentType Journal Article
Copyright COPYRIGHT 2025 BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2025 BioMed Central Ltd.
DOI 10.1186/s13046-025-03344-4
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID A828900189
GroupedDBID ---
0R~
29K
2WC
4.4
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABDBF
ABUWG
ACGFO
ACGFS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
D-I
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M1P
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
~8M
PMFND
ID FETCH-LOGICAL-g989-8d62787af0a01ceac615b159278fd14d780875d4e3585a9343cc893fa8a436773
ISSN 0392-9078
IngestDate Tue Jun 17 21:58:50 EDT 2025
Tue Jun 10 21:00:56 EDT 2025
Thu May 22 21:23:48 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-g989-8d62787af0a01ceac615b159278fd14d780875d4e3585a9343cc893fa8a436773
ParticipantIDs gale_infotracmisc_A828900189
gale_infotracacademiconefile_A828900189
gale_healthsolutions_A828900189
PublicationCentury 2000
PublicationDate 20250226
PublicationDateYYYYMMDD 2025-02-26
PublicationDate_xml – month: 02
  year: 2025
  text: 20250226
  day: 26
PublicationDecade 2020
PublicationTitle Journal of experimental & clinical cancer research
PublicationYear 2025
Publisher BioMed Central Ltd
Publisher_xml – name: BioMed Central Ltd
SSID ssj0061919
Score 2.3960373
SourceID gale
SourceType Aggregation Database
SubjectTerms Antimitotic agents
Antineoplastic agents
Title Retraction Note: The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiEuiKcolDIHKg6Wwfb6FW5JaYkqNQcIUuFSrdfrxmqxq8QBxI_g13DiCDd-FTPrjR8qSIVDrHi9WW88n8azs_PNMPbEi-IkiRJlZ8qLcIESKFtwx7G9UIRZpiIn1cmqD6fh5K1_cBQcDQa_OlFLqyp5Jr_8kVfyP1LFNpQrsWT_QbLNoNiA31G-eEQJ4_FSMn6tqoWp9T0tK7WOoCgLWeJvcmm9Ks9Ocut8Xi7xo1My5IXFrbP8FHvh31WfTRxsQYXNhRFVE5GeL88pVI4YL0uyM0kJ4Fn5ERfYqBck1SEqyg-izvgq60pphn413bdpEz7e29n1dsajsUWRIqImv6PV-Un09pM7dnGv5gABsyFvSprAwjL5iRo_9qT2os9RrQnzHtYbLSvt8-80vVk7xw9w9vOyvfBS1e3vKM6z6wfxal55-BefeCcmSlPDhp49dOpaQWu1X6ed7ML74ttEb24tXdo9tvUtOfd9w0rqZ-ke0cqVKhwOr7CrHi5ZNJdw_H5tFeA6VReZaaayJnDF4fOLNzD2QcfSmd1kN4woYFTj7RYbqOI2u3ZogjDusG8t7IBg9wIQdNCADjTooA864ECggz7oIF9CCzog0EEDOmhBB3hmQAcN6ABBBy3oAEEHCLqfX398H0MDNjBgu8tm-3uz3Yltin_YJxTFF6chqpFIZI5wXInWAVreCZre2Jilrp9GMZViSH3Fcb0rhtznUqLpnYlY-DyMIn6PbRRloe4zkI4vqKhO5riJ70apDh1w0yRIuAqCQG2yx_Swj2vicaMXjluRbrKnugeBgx6wMNQVHJ-yp_V6bvV6oq6WncsPLj3QQ3a9BfkW26gWK_UIzd8q2dZuo22Nrt8DXLnu
linkProvider BioMedCentral
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retraction+Note%3A+The+oncogenic+Golgi+phosphoprotein+3+like+overexpression+is+associated+with+cisplatin+resistance+in+ovarian+carcinoma+and+activating+the+NF-%C3%8E%C2%BAB+signaling+pathway&rft.jtitle=Journal+of+experimental+%26+clinical+cancer+research&rft.au=He%2C+Shanyang&rft.au=Niu%2C+Gang&rft.au=Shang%2C+Jianhong&rft.au=Deng%2C+Yalan&rft.date=2025-02-26&rft.pub=BioMed+Central+Ltd&rft.issn=0392-9078&rft.volume=44&rft.issue=1&rft_id=info:doi/10.1186%2Fs13046-025-03344-4&rft.externalDocID=A828900189
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0392-9078&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0392-9078&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0392-9078&client=summon